A new type of hormonal treatment has been shown to extend life for men with advanced prostate cancer. The once-daily pill, known as MDV3100, is the first in a new class of medicines called androgen receptor signaling inhibitors (ARSI). The drug has been designed to bind to the receptors on prostate cancer cells that normally…